Company profile

Sumitomo Pharma Co., Ltd.

EDINET
E00922
Securities
4506
Industry
Pharmaceutical
Industry Peer Ranking
View Company Rankings
Latest annual securities report
2026-06-23 Annual Securities Report PDF HTML
Latest financial report
2026-11-02 Semiannual Securities Report PDF HTML
Latest filing
—

Industry position

Pharmaceutical

View details
Profitability Very strong Current Top 4% 5-year trend Improving
Financial strength Weak Based on Equity ratio Current Bottom 8% 5-year trend Broadly stable
Cash generation Strong Current Top 16%

Latest half-year results

H1 FY2027

2026/04/01 - 2026/09/30

Consolidated · IFRS · Cumulative YTD

For H1 FY2027, revenue was ¥266.49 billion. Operating income was ¥42.28 billion, down 56.0% year over year. Net income was ¥38.24 billion, down 61.3% year over year.

Revenue ¥266.49B
Operating income ¥42.28B down 56.0% year over year
Net income ¥38.24B down 61.3% year over year
Operating cash flow ¥16.67B
Free cash flow ¥17.21B
Total assets ¥851.05B
Total equity ¥431.11B

Half-year trend

Half-year financial trend

H1 values are cumulative year-to-date.

H2 values are calculated when comparable.

Consolidated · IFRS · Cumulative YTD

Mode

Half-year financial data

Annual key financial indicators

FY2026

Consolidated IFRS

Revenue reached ¥453.29 billion, up 13.7% year over year. Operating income was ¥107.34 billion, up 272.6% year over year. Operating margin was 23.7%. Net income was ¥106.87 billion, up 352.2% year over year. ROE was 46.3%; equity ratio was 36.4%; free cash flow was ¥94.26 billion.

Revenue ¥453.29B up 13.7% year over year
Operating income ¥107.34B up 272.6% year over year
Net income ¥106.87B up 352.2% year over year
Total assets¥804.57B
Total equity¥292.47B
Operating cash flow¥71.72B
Free cash flow¥94.26B

Industry position details

Pharmaceutical

Annual data for the same fiscal year and industry

Comparison sample varies by metric

Profitability Very strong

Operating margin Top 10% / ROE Top 3%

Financial strength Weak
Based on Equity ratio

Equity ratio Bottom 94%

Cash generation Strong

Operating cash flow margin Top 26% / Free cash flow margin Top 10%

Profitability Industry position history Improving
2026 Top 4% 2025 Top 8% 2024 Bottom 10% 2023 Bottom 37% 2022 Top 23%
Financial strength Industry position history Broadly stable
2026 Bottom 8% 2025 Bottom 4% 2024 Bottom 4% 2023 Bottom 5% 2022 Bottom 16%
Profitability Operating margin 23.7% Industry median 6.9% Top 10% Comparison sample 42
Profitability ROE 46.3% Industry median 3.8% Top 3% Comparison sample 48
Financial strength Equity ratio 36.4% Industry median 68.3% Bottom 94% Comparison sample 50
Cash generation Operating cash flow margin 15.8% Industry median 7.4% Top 26% Comparison sample 43
Cash generation Free cash flow margin 20.8% Industry median -0.6% Top 10% Comparison sample 43

Annual financial data

Implied share price and market capitalization are estimated from EDINET filing data, not real-time market prices.

Fiscal year Scope Accounting standard Revenue Operating income Ordinary income Profit before tax Net income Profit attributable to owners of parent Comprehensive income Total assets Total liabilities Net assets Shareholders' equity Equity Equity attributable to owners of parent Equity for ratio Operating cash flow Investing cash flow Financing cash flow Free cash flow Cash and cash equivalents Basic EPS P/E Implied Share Price Implied Market Capitalization Book value per share Dividend per share Shares issued Equity ratio Official equity ratio ROE ROA Operating margin Ordinary income margin Net margin Operating cash flow margin Free cash flow margin Dividend payout ratio Revenue YoY Operating income YoY Ordinary income YoY Profit before tax YoY Net income YoY Total assets YoY Equity YoY Operating cash flow YoY Investing cash flow YoY Financing cash flow YoY Free cash flow YoY Cash and cash equivalents YoY EPS YoY Dividend per share YoY Shares issued YoY Employees YoY Average salary YoY Employees Average salary
FY2026 Consolidated IFRS 453294000000 107338000000 100344000000 106865000000 106865000000 122990000000 804571000000 512104000000 292467000000 292467000000 292467000000 71715000000 22549000000 -91266000000 94264000000 44310000000 268.99 7.7 2071.223 8.241396317E+11 736.16 3.979E+8 0.3635067632 0.364 0.4626731263 0.1328223364 0.2367955455 0.2357520726 0.1582085799 0.2079533371 0.1365537369 2.72649632 4.6978025098 3.5216637048 0.0834455511 3.3463636364 -0.7739539267 0.1614355544 -0.1891547818 0.916854127 3.521600269 0.0 -0.1850208768 0.2697025213 3123 9055526
FY2025 Consolidated IFRS 28804000000 17611000000 23634000000 23634000000 13417000000 23116000000 59.49 12.3 731.727 2.911541733E+11 426.59 3.979E+8 0.228 0.1451978547 1.0545039831 -0.2041863187 1.0750387871 0.0 -0.2305220884 -0.1781803139 3832 7132006
FY2024 Consolidated IFRS -354859000000 -323114000000 -314969000000 -314969000000 -250345000000 29047000000 -792.79 392.82 3.979E+8 0.172 -1.1192689566 -5.7427796327 -0.797550844 -3.2270861104 0.0 -0.2032 -0.0404291311 4980 8678310
FY2023 Consolidated IFRS -76979000000 -47920000000 -74512000000 -74512000000 -35085000000 143478000000 -187.55 1023.8 21.0 3.979E+8 0.358 -0.1468742023 -0.1119701413 -2.2779991367 -1.5776208098 -2.3208303051 -0.2931561108 -2.3208676667 -0.25 0.0 -0.1054816087 0.0029200619 6250 9043949
FY2022 Consolidated IFRS 60234000000 82961000000 56413000000 56413000000 28161000000 202984000000 141.99 8.5 1206.915 4.802314785E+11 1530.08 28.0 3.979E+8 0.465 0.094934781 0.1971969857 -0.1543019207 0.0656382063 0.0034507907 0.0479406086 0.0034628975 0.0 0.0 0.0241864556 0.0056720618 6987 9017617
FY2021 Consolidated IFRS 71224000000 77851000000 56219000000 56219000000 41007000000 193698000000 141.5 13.6 1924.40 7.65718760E+11 1461.31 28.0 3.979E+8 0.444 0.1010006827 0.1978798587 -0.1443433967 -0.0726172466 0.3795058033 0.9044519605 0.3794111913 0.0 0.0 0.0565277993 -0.0072090292 6822 8966757
FY2020 Consolidated IFRS 83239000000 83947000000 40753000000 40753000000 39932000000 101708000000 102.58 13.7 1405.346 5.591871734E+11 1332.72 28.0 3.979E+8 0.423 0.0793150796 0.2729576916 0.4380312349 0.2905789749 -0.1619265017 -0.2592063862 -0.1618596291 0.0 0.0 0.0516286645 0.0136558225 6457 9031868
FY2019 Consolidated IFRS 57884000000 65046000000 48627000000 48627000000 56195000000 137296000000 122.39 22.4 2741.536 1.0908571744E+12 1253.82 28.0 3.979E+8 0.597 0.1022799337 0.2287768609 -0.3435178569 -0.2335446469 -0.0901998204 -0.0709118592 -0.0902400951 0.0 0.0 -0.020421187 6140 8910192
FY2018 Consolidated IFRS 477966000000 60887000000 483050000000 483050000000 147775000000 1215.84 28.0 3.979E+8 0.603 0.1273877221 0.1611290475 0.1258066305 0.0486132819 0.3993447156 0.4 0.0 -0.0345040049 6268
FY2017 Consolidated IFRS 411638000000 52759000000 54341000000 47217000000 28991000000 28991000000 793950000000 333293000000 460656000000 401221000000 460656000000 21624000000 -59729000000 9881000000 -38105000000 105603000000 72.97 25.2 1838.844 7.316760276E+11 1159.47 20.0 3.979E+8 0.5802078217 0.58 0.0365148939 0.1281684393 0.1320116219 0.0704283861 0.0525315933 -0.0925691992 0.2740852405 0.0209123872 0.4286604024 0.5428579541 0.193554095 0.1738672713 0.1218498972 0.0317690695 -0.5624000809 -4.7596147794 1.231921136 -1.5835196472 -0.2210732067 0.1739060489 0.1111111111 0.0 -0.0306107212 6492

Source filings

Select a document type to load the filings list.

Select a filing type to load the list.

Document filter

Select filing types

Choose the filing types to display.

Filing types containing financial data are selected by default.

Source: FSA EDINET / Data and metrics: bestforever.jp
New EDINET filings are typically imported within minutes, with financial data and analysis results updated accordingly.